The pattern of PHLDA3 is overexpressed in cholangiocarcinoma, brain cancers, kidney cancers, testicular cancer, and lymphoma; however, it has lower expression in colon, esophageal, sarcoma, and stomach cancers (Figure 2C). This evidence concerns the gene PHLDA3 and sarcoma.